FIP1L1-PDGFRА-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy
The described case of FIP1L1-PDGFRА-positive myeloproliferative disease is characterized by an atypical aggressive course to develop severe specific complications as injuries to the brain, heart, lung, and intestine. Pathogenetic therapy with imatinib could stabilize a patient’s state, but failed to...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2015-12-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/31887 |
_version_ | 1818258968422645760 |
---|---|
author | I S Nemchenko A G Turkina E Yu Chelysheva G M Galstyan A M Kovrigina N K Khuazheva V G Savchenko |
author_facet | I S Nemchenko A G Turkina E Yu Chelysheva G M Galstyan A M Kovrigina N K Khuazheva V G Savchenko |
author_sort | I S Nemchenko |
collection | DOAJ |
description | The described case of FIP1L1-PDGFRА-positive myeloproliferative disease is characterized by an atypical aggressive course to develop severe specific complications as injuries to the brain, heart, lung, and intestine. Pathogenetic therapy with imatinib could stabilize a patient’s state, but failed to produce a complete hematological response. Switching from imatinib to dasatinib could produce sustained clinical, hematological, and molecular remissions. |
first_indexed | 2024-12-12T18:07:58Z |
format | Article |
id | doaj.art-0e14bdbcc0964fee84f3d820fdd9b587 |
institution | Directory Open Access Journal |
issn | 0040-3660 2309-5342 |
language | Russian |
last_indexed | 2024-12-12T18:07:58Z |
publishDate | 2015-12-01 |
publisher | "Consilium Medicum" Publishing house |
record_format | Article |
series | Терапевтический архив |
spelling | doaj.art-0e14bdbcc0964fee84f3d820fdd9b5872022-12-22T00:16:27Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422015-12-018712899528903FIP1L1-PDGFRА-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapyI S NemchenkoA G TurkinaE Yu ChelyshevaG M GalstyanA M KovriginaN K KhuazhevaV G SavchenkoThe described case of FIP1L1-PDGFRА-positive myeloproliferative disease is characterized by an atypical aggressive course to develop severe specific complications as injuries to the brain, heart, lung, and intestine. Pathogenetic therapy with imatinib could stabilize a patient’s state, but failed to produce a complete hematological response. Switching from imatinib to dasatinib could produce sustained clinical, hematological, and molecular remissions.https://ter-arkhiv.ru/0040-3660/article/view/31887hypereosinophilic syndromeclonal myeloproliferative disease with eosinophiliaimatinibdasatinib |
spellingShingle | I S Nemchenko A G Turkina E Yu Chelysheva G M Galstyan A M Kovrigina N K Khuazheva V G Savchenko FIP1L1-PDGFRА-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy Терапевтический архив hypereosinophilic syndrome clonal myeloproliferative disease with eosinophilia imatinib dasatinib |
title | FIP1L1-PDGFRА-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy |
title_full | FIP1L1-PDGFRА-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy |
title_fullStr | FIP1L1-PDGFRА-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy |
title_full_unstemmed | FIP1L1-PDGFRА-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy |
title_short | FIP1L1-PDGFRА-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy |
title_sort | fip1l1 pdgfrа positive myeloproliferative disease with eosinophilia a rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy |
topic | hypereosinophilic syndrome clonal myeloproliferative disease with eosinophilia imatinib dasatinib |
url | https://ter-arkhiv.ru/0040-3660/article/view/31887 |
work_keys_str_mv | AT isnemchenko fip1l1pdgfrapositivemyeloproliferativediseasewitheosinophiliaararecasewithmultipleorgandysfunctionandaresponsetotyrosinekinaseinhibitortherapy AT agturkina fip1l1pdgfrapositivemyeloproliferativediseasewitheosinophiliaararecasewithmultipleorgandysfunctionandaresponsetotyrosinekinaseinhibitortherapy AT eyuchelysheva fip1l1pdgfrapositivemyeloproliferativediseasewitheosinophiliaararecasewithmultipleorgandysfunctionandaresponsetotyrosinekinaseinhibitortherapy AT gmgalstyan fip1l1pdgfrapositivemyeloproliferativediseasewitheosinophiliaararecasewithmultipleorgandysfunctionandaresponsetotyrosinekinaseinhibitortherapy AT amkovrigina fip1l1pdgfrapositivemyeloproliferativediseasewitheosinophiliaararecasewithmultipleorgandysfunctionandaresponsetotyrosinekinaseinhibitortherapy AT nkkhuazheva fip1l1pdgfrapositivemyeloproliferativediseasewitheosinophiliaararecasewithmultipleorgandysfunctionandaresponsetotyrosinekinaseinhibitortherapy AT vgsavchenko fip1l1pdgfrapositivemyeloproliferativediseasewitheosinophiliaararecasewithmultipleorgandysfunctionandaresponsetotyrosinekinaseinhibitortherapy |